{
  "@context": {
    "biotools": "https://bio.tools/ontology/",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "dct": "http://purl.org/dc/terms/",
    "edam": "http://edamontology.org/",
    "owl": "http://www.w3.org/2002/07/owl#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://bio.tools/covid19-drug-repurposing",
      "@type": "sc:SoftwareApplication",
      "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalTool/0.6-DRAFT",
      "sc:additionalType": "Script",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_3400"
        },
        {
          "@id": "edam:topic_3474"
        },
        {
          "@id": "edam:topic_3379"
        },
        {
          "@id": "edam:topic_0602"
        },
        {
          "@id": "edam:topic_3377"
        }
      ],
      "sc:citation": [
        "pubmed:33716737",
        {
          "@id": "https://doi.org/10.3389/FPHAR.2021.598925"
        },
        "pmcid:PMC7952300"
      ],
      "sc:description": "COVID-19 drug repurposing system for In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19.",
      "sc:featureList": [
        {
          "@id": "edam:operation_3925"
        },
        {
          "@id": "edam:operation_3454"
        },
        {
          "@id": "edam:operation_3938"
        }
      ],
      "sc:license": "MIT",
      "sc:name": "COVID-19 drug repurposing",
      "sc:url": "https://github.com/muntisa/immuno-drug-repurposing-COVID-19"
    },
    {
      "@id": "https://doi.org/10.3389/FPHAR.2021.598925",
      "@type": "sc:CreativeWork"
    }
  ]
}